KPTI Stock Analysis: Buy, Sell, or Hold?
KPTI - Karyopharm Therapeutics Inc.
$6.52
-0.11 (-1.66%)
▼
5d:
-1.06%
30d:
-10.81%
90d:
+7.24%
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
15d
Get Alerted When KPTI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: KPTI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: KPTI shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: KPTI is currently trading at $6.52, which is considered slightly low relative to its 30-day fair value range of $6.51 to $7.81.
Technical Outlook: Technically, KPTI is in a uptrend. Immediate support is located at $5.88, while resistance sits at $7.20.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.33 (+135.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, KPTI is in a uptrend. Immediate support is located at $5.88, while resistance sits at $7.20.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.33 (+135.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$6.51 -
$7.81
Company Quality Score
50/100
(HOLD)
Options IV Signal
42th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 42th percentile)
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 135.2% below Wall St target ($15.33)
Fair Price Analysis
30-Day Fair Range
$6.51 -
$7.81
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$1.19
(18.2%)
Support & Resistance Levels
Support Level
$5.88
Resistance Level
$7.20
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-1.32
Wall Street Target
$15.33
(+135.2%)
Revenue Growth (YoY)
13.6%
Profit Margin
-87.4%
Last updated: February 01, 2026 11:04 PM ET
Data refreshes hourly during market hours. Next update: 12:04 AM
Data refreshes hourly during market hours. Next update: 12:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KPTI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Kristin Abate
SELL
362 shares
2025-10-01
Kristin Abate
SELL
23 shares
2025-09-15
Michael Mano
SELL
234 shares
2025-09-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$117 | 59 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$140 | 59 HOLD |
